ALLIED HEALTHCARE PRODUCTS INC
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $6.9M | $8.0M | $31.9M | $8.3M | $8.5M | $33.5M |
| Operating income | −$1.2M | −$381,000 | −$3.1M | −$353,000 | −$888,000 | −$2.1M |
| Net income | −$1.3M | −$413,000 | −$3.0M | $378,000 | −$901,000 | −$2.1M |
| Total assets | $19.7M | $17.7M | $19.7M | $15.5M | $17.3M | $19.6M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $5.2M | $10.6M | $8.9M | $11.9M | $14.0M | $16.2M |
| EPS (diluted) | $-0.32 | $-0.10 | $-0.75 | $0.09 | $-0.22 | $-0.52 |
| Shares out. | 4.0M | 4.0M | 4.0M | 4.0M | 4.0M | 4.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −17.9%
- Net margin
- −18.6%
- Return on equity
- −24.5%
- Return on assets
- −6.5%
- Return on capital (ROCE)
- −9.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.30
- Revenue growth (YoY)
- −13.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Accruals / assets
- 14.3%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2023
- NT 10-Qmissed a reporting deadline ↗Feb 14, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2022
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Weil John DDirector | Nov 26, 2021 | Sell | 69,249 | $8.44 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Completed an acquisition or dispositionJul 18, 2023
- Results of operationsMay 15, 2023
- Entered a material agreement · Bankruptcy or receivership · New financial obligation · Debt acceleration / triggering event · Other material eventMay 12, 2023
- Entered a material agreement · Debt acceleration / triggering event · Costs from exit or disposal · Material impairment · Other material eventMar 16, 2023
- Entered a material agreement · Director / officer changeFeb 27, 2023
- Results of operationsFeb 14, 2023
- Director / officer changeFeb 8, 2023
- Entered a material agreement · Other material eventJan 31, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KJul 18, 2023
- 8-KFORM 8-KMay 15, 2023
- NT 10-QMay 15, 2023
- 8-KFORM 8-KMay 12, 2023
- 8-KFORM 8-KMar 16, 2023
- 25-NSEMar 3, 2023
- 8-KFORM 8-KFeb 27, 2023
- 8-KFORM 8-KFeb 14, 2023
- NT 10-QFeb 14, 2023
- 8-KFORM 8-KFeb 8, 2023
- 8-KFORM 8-KJan 31, 2023
- 8-KFORM 8-KJan 26, 2023
- 8-KFORM 8-KJan 11, 2023
- 8-KFORM 8-KDec 22, 2022
- 8-KFORM 8-KDec 13, 2022